ALT earnings date and last-quarter result: last quarter miss, P/E -3.02. Updated 2026-07-23.
Altimmune (ALT) Research Hub
Altimmune (ALT) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 2.05 USD (-3.30%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -3.02, market cap 0.24B. This hub links to the full technical, earnings and options research available for ALT.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 2.05 USD (-3.30%) |
| 52-week range | 2.02 USD – 3.55 USD |
| Trend regime | Range |
| 14-day RSI | 17 (Oversold) |
| Trailing P/E | -3.02 |
| Market cap | 0.24B |
| Dividend yield | 0.00% |
Available research for ALT
Covered Call on ALT: how it works, illustrative setup around the real 2.05 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ALT: how it works, illustrative setup around the real 2.05 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ALT: how it works, illustrative setup around the real 2.05 USD price, max profit/loss, breakeven and when to use it. Educational.
ALT technical analysis: range, last 2.05 USD, RSI 17, 52w range 2.02 USD–3.55 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is ALT in?
Altimmune (ALT) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is ALT in an uptrend or downtrend?
As of 2026-10-26, ALT is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ALT's trailing P/E ratio?
ALT's trailing P/E is -3.02, with a market cap of 0.24B. See the earnings research page for full valuation detail.